Tonghua Dongbao announced that recently, the Mendon insulin injection developed by the company in cooperation with Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. has officially obtained a biological product license approval letter for Mendon insulin injections issued by the US Food and Drug Administration, and has been approved for listing by the FDA.

Tonghua Dongbao announced that recently, the Mendon insulin injection developed by the company in cooperation with Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. has officially obtained a biological product license approval letter for Mendon insulin injections issued by the US Food and Drug Administration, and has been approved for listing by the FDA.